Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 4351-4400 of 6034 result(s).
CYDY CytoDyn Inc
12/28/2020 5:15:00 AM
Since it is an extension it will be (6)
CYDY CytoDyn Inc
12/27/2020 11:22:10 AM
That supply is no longer being used
CYDY CytoDyn Inc
12/27/2020 11:17:45 AM
all cancers rely on glucose and glu (1)
CYDY CytoDyn Inc
12/27/2020 10:52:22 AM
My previous reasoning was that the (4)
CYDY CytoDyn Inc
12/26/2020 7:17:17 PM
It depends on what you mean by immi (8)
CYDY CytoDyn Inc
12/25/2020 5:23:40 PM
I wouldn't expect Alzheimer's trial (6)
CYDY CytoDyn Inc
12/25/2020 2:07:06 AM
Since the FDA just wants the placeb (6)
CYDY CytoDyn Inc
12/25/2020 2:04:05 AM
Guidance? I don’t know what that (3)
CYDY CytoDyn Inc
12/25/2020 1:49:14 AM
Well actually Cytodyn will submit t (3)
CYDY CytoDyn Inc
12/25/2020 1:16:40 AM
Data can be released from the DSMC (1)
CYDY CytoDyn Inc
12/25/2020 1:13:58 AM
Would the FDA waste time providing (2)
CYDY CytoDyn Inc
12/25/2020 1:06:59 AM
The data could be added as an adden
CYDY CytoDyn Inc
12/25/2020 1:04:31 AM
Open label merely means the results (2)
CYDY CytoDyn Inc
12/25/2020 1:01:39 AM
Since it will be the same protocol (2)
CYDY CytoDyn Inc
12/25/2020 12:28:21 AM
Since 42 days is out the window the
CYDY CytoDyn Inc
12/25/2020 12:07:20 AM
So those you deem not fit to live s (5)
CYDY CytoDyn Inc
12/24/2020 11:56:07 PM
The supply is already paid for and
CYDY CytoDyn Inc
12/24/2020 8:20:50 PM
United States, Alabama Advanced Ca (1)
CYDY CytoDyn Inc
12/24/2020 8:19:37 PM
"and on Christmas Eve out of nowher (3)
CYDY CytoDyn Inc
12/24/2020 8:10:09 PM
Patients at any hospital where we h (18)
CYDY CytoDyn Inc
12/23/2020 12:44:16 PM
Oncoimmune was doing the trial at t
CYDY CytoDyn Inc
12/23/2020 11:41:13 AM
They have a somewhat worse off pati (2)
CYDY CytoDyn Inc
12/23/2020 3:45:13 AM
You're new, sell your shares. (8)
CYDY CytoDyn Inc
12/23/2020 2:50:59 AM
Indeed the EIND is an ethical probl
CYDY CytoDyn Inc
12/23/2020 2:47:07 AM
I misremembered. In CD02 they went (2)
CYDY CytoDyn Inc
12/23/2020 2:08:23 AM
Borrowing shares can be fairly chea (1)
CYDY CytoDyn Inc
12/22/2020 9:43:12 PM
It would be interesting to see who (2)
CYDY CytoDyn Inc
12/22/2020 9:39:43 PM
Which also shows remdesivir is a fa (6)
CYDY CytoDyn Inc
12/22/2020 9:36:36 PM
The anti-coagulants overly ramp up (6)
CYDY CytoDyn Inc
12/22/2020 6:27:36 PM
I’m actually surprised they didn' (24)
CYDY CytoDyn Inc
12/22/2020 6:20:55 PM
Seems everything thats ever been ut (10)
CYDY CytoDyn Inc
12/22/2020 5:18:02 PM
CYDY isn't a religious cult to cuss (6)
CYDY CytoDyn Inc
12/22/2020 11:38:30 AM
Sykes went short. (1)
CYDY CytoDyn Inc
12/22/2020 1:35:27 AM
But what, oh what does it mean? Doe (10)
CYDY CytoDyn Inc
12/21/2020 9:06:46 PM
Edited to match the print edition?
CYDY CytoDyn Inc
12/21/2020 8:49:10 PM
EINDs for everything but COVID-19 n (3)
CYDY CytoDyn Inc
12/21/2020 1:27:12 PM
Of note: $CYDY has a larger ROI in (6)
CYDY CytoDyn Inc
12/20/2020 11:51:58 PM
Typical AI writing for humans. We p (3)
CYDY CytoDyn Inc
12/20/2020 5:41:17 PM
Published online 2013 Apr 18. When
CYDY CytoDyn Inc
12/20/2020 5:17:02 PM
Cytolin, a study in failure. https:
CYDY CytoDyn Inc
12/20/2020 4:58:21 PM
I understand the present value . Wh
CYDY CytoDyn Inc
12/20/2020 4:46:53 PM
But I bet many investors here from
CYDY CytoDyn Inc
12/20/2020 4:39:43 PM
You want the job? https://www.cytod
CYDY CytoDyn Inc
12/20/2020 4:34:30 PM
You made a claim that NP resurrecte (13)
CYDY CytoDyn Inc
12/20/2020 4:21:40 PM
83% survival and it seems like most (2)
CYDY CytoDyn Inc
12/20/2020 1:46:08 AM
Bill is one of us that's why he's p (6)
CYDY CytoDyn Inc
12/19/2020 10:42:17 PM
Unless of course you just want a bo (8)
CYDY CytoDyn Inc
12/19/2020 4:47:14 AM
With Cytodyn stock is he seeking .3
CYDY CytoDyn Inc
12/19/2020 4:44:23 AM
May your Uncle get well and get ler (3)
CYDY CytoDyn Inc
12/19/2020 4:40:30 AM
there are way too many retail inves (3)
Go to page:
  • << First
  • < Previous
  • 87
  • 88
  • Next >

Recent Articles

  • Savara Inc. Class Action: Key Information for Investors
  • Regeneron Advances Garetosmab in Breakthrough Genetic Therapy
  • Coastal Medical Transportation Secures Emergency Contract in MA
  • SBM Offshore Updates on Share Repurchase Progress and Milestones
  • Transforming $1000 into $18000 with Fabrinet's Growth Strategy
  • Dogecoin ETF Trading: Potential Surge to 60 Cents Ahead
  • Recent Developments in the Space Investment Sector
  • Walmart's AI Innovations and Sales Growth Reflect Future Potential
  • JLL Income Property Trust Expands Portfolio with Smart Acquisition
  • Kin Insurance Achieves Outstanding 4.9 Trustpilot Rating
  • Lennar's Q3 Results: Will Rate Cuts Propel Its Stock Growth?
  • Continuous Support for Children and Alzheimer's Causes Ahead
  • Edgewood Country Club Lawsuit Highlights Serious Workplace Issues
  • Family Care Center Achieves Top Award for Candidate Experience
  • Connected Health & Safety Association: A Bold New Chapter
  • Engaging Voter Education During Congressional District 7 Vacancy
  • Innovative Wall Switch Shield Developed for Greater Device Control
  • Revolutionizing Palletizing Solutions with Flex Stack Technology
  • Coastal Medical Transportation System Expands Emergency Services in MA
  • Berry Corporation Shareholder Rights Investigation Uncovered
  • Nike Focuses on Sales Recovery Amid Tariff Challenges
  • Long-Term Gains: How Ares Management Stock Blossomed Over Time
  • DSW Enhances Shopping Experience with Uber Eats Partnership
  • Maximizing Digital Marketing Success in a Cookieless World
  • Strategic Investment Shift: Patriot Financial Partners Strengthens Ties with NewtekOne
  • LightPath Technologies Secures Major Order, Stock Soars
  • Understanding the Stabilisation Options for DEC Shares
  • Palantir Technologies Faces Growing Competition from Salesforce
  • Wolters Kluwer Boosts Share Buyback Plan Amid Strong Outlook
  • Tesla's Journey in India: Lessons from Apple's Success
  • Strategic Equity Exchange Strengthens NewtekOne's Position
  • FedEx Earnings Outlook: Anticipating a Revival Amid Challenges
  • Comcast's Short Interest Trends and Market Sentiment Analysis
  • Understanding SharpLink Gaming's Short Interest Trends
  • Understanding Market Sentiment for Marvell Technology Inc. Shares
  • Unlocking Healthcare: Retrieve Medical's ID.me Integration
  • Roivant Sciences Advancements in Dermatomyositis Treatment
  • Get Ready for for KING + COUNTRY's New Single 'World on Fire'
  • Market Movements: Nasdaq Dips While General Mills Shines
  • Wheeler Bio Partners with MindImmune on Alzheimer’s Research
  • Kin Insurance Celebrates Trustpilot Success with Stellar Ratings
  • Transport Credit Union™ Unveils Brand Refresh for 2025 Vision
  • Innovative Bird Protection Technology for Jet Engines
  • Katie's Authentic Pizzas Reach New Heights with Target Deal
  • Exciting Partnership: DSW and Uber Eats Team Up for Delivery
  • Gurucul Launches Advanced AI Solution for Insider Threats
  • Transforming $1000 into Significant Gains with COF Investment
  • Paul Graham Urges Young Innovators to Prioritize Learning
  • Azerion Group Successfully Places New Bonds to Enhance Growth
  • CIMG Inc. Partners with iZUMi for a Transformative Fund Launch
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site